{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:30:42Z","timestamp":1785231042843,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s12325-019-01017-1","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T11:04:31Z","timestamp":1562065471000},"page":"2450-2462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects"],"prefix":"10.1007","volume":"36","author":[{"given":"Joris","family":"Vandenbossche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Jessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"van den Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeike","family":"Biewenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Martin","family":"Berke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Talloen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loeckie","family":"De Zwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Snoeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeysen","family":"Yogaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"1017_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"Polaris Observatory Collaborators","year":"2018","unstructured":"Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383\u2013403.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"1017_CR2","volume-title":"Hepatitis B virus in human diseases. Molecular and translational medicine","author":"D Lavanchy","year":"2016","unstructured":"Lavanchy D, Kane M. Global epidemiology of hepatitis B virus infection. In: Liaw YF, Zoulim F, editors. Hepatitis B virus in human diseases. Molecular and translational medicine. New York: Humana Press; 2016."},{"key":"1017_CR3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S1473-3099(16)30204-3","volume":"16","author":"S Nayagam","year":"2016","unstructured":"Nayagam S, Thursz M, Sicuri E, et al. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis. 2016;16:1399\u2013408.","journal-title":"Lancet Infect Dis."},{"key":"1017_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S2468-1253(17)30140-1","volume":"2","author":"M Bourliere","year":"2017","unstructured":"Bourliere M. Hepatitis B treatment: could we extend the current treatment indication? Lancet Gastroenterol Hepatol. 2017;2:543\u20134.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"1017_CR5","first-page":"e00680","volume":"61","author":"AM Lam","year":"2017","unstructured":"Lam AM, Ren S, Espiritu C, et al. Hepatitis B virus capsid assembly modulators, but not nucleoside analogs, inhibit the production of extracellular pregenomic RNA and spliced RNA variants. Antimicrob Agents Chemother. 2017;61:e00680\u201317.","journal-title":"Antimicrob Agents Chemother."},{"key":"1017_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.21037\/atm.2017.03.69","volume":"5","author":"ASJ Woo","year":"2017","unstructured":"Woo ASJ, Kwok R, Ahmed T. Alpha-interferon treatment in hepatitis B. Ann Transl Med. 2017;5:159.","journal-title":"Ann Transl Med"},{"key":"1017_CR7","unstructured":"World Health Organization.\u00a0Combating hepatitis B and C to reach elimination by 2030: An advocacy brief. Geneva: World Health Organization; 2016. http:\/\/apps.who.int\/iris\/bitstream\/10665\/206453\/1\/WHO_HIV_2016.04_eng.pdf?ua=1. Accessed 19 Feb 2019."},{"key":"1017_CR8","doi-asserted-by":"publisher","first-page":"10262","DOI":"10.1128\/JVI.01360-08","volume":"82","author":"C Bourne","year":"2008","unstructured":"Bourne C, Lee S, Venkataiah B, Lee A, Korba B, Finn MG, Zlotnick A. Small-molecule effectors of hepatitis B virus capsid assembly modulators give insight into virus life cycle. J Virol. 2008;82:10262\u201310270.\u00a0","journal-title":"J Virol"},{"key":"1017_CR9","doi-asserted-by":"crossref","unstructured":"Kakuda TN, Yogaratnam JZ, Westland C, et al. JNJ-64530440, a novel capsid assembly modulator: single- and multiple-ascending dose safety, tolerability and pharmacokinetics in healthy volunteers. EASL, Vienna, Austria, 10\u201314 April 2019; Poster FRI-180.","DOI":"10.1016\/S0618-8278(19)30925-9"},{"key":"1017_CR10","unstructured":"Berke JM. Capsid assembly modulator JNJ-56136379 prevents de novo infection of primary human hepatocytes with hepatitis B virus. AASLD, Boston MA, USA, November 11\u201315 2016; Abstract 234."},{"key":"1017_CR11","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/jps.20804","volume":"96","author":"LM Berezhkovskiy","year":"2007","unstructured":"Berezhkovskiy LM. The connection between the steady state (Vss) and terminal (V\u03b2) volumes of distribution in linear pharmacokinetics and the general proof that V\u03b2\u2009\u2265\u2009Vss. J Pharm Sci. 2007;96:1638\u201352.","journal-title":"J Pharm Sci"},{"key":"1017_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2165\/11587230-000000000-00000","volume":"50","author":"A Van den Bergh","year":"2011","unstructured":"Van den Bergh A, Sinha V, Gilissen R, et al. Prediction of human oral plasma concentration-time profiles using preclinical data: comparative evaluation of prediction approaches in early pharmaceutical discovery. Clin Pharmacokinet. 2011;50:505\u201317.","journal-title":"Clin Pharmacokinet"},{"key":"1017_CR13","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1124\/dmd.112.046425","volume":"40","author":"L Di","year":"2012","unstructured":"Di L, Trapa P, Obach RS, et al. A novel relay method for determining low-clearance values. Drug Metab Dispos. 2012;40:1860\u20135.","journal-title":"Drug Metab Dispos"},{"issue":"67","key":"1017_CR14","first-page":"370","volume":"2017","author":"European Association for the Study of the Liver (EASL)","year":"2017","unstructured":"European Association for the Study of the Liver (EASL). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Hepatology. 2017;2017(67):370\u201398.","journal-title":"Hepatology"}],"updated-by":[{"DOI":"10.1007\/s12325-020-01249-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-019-01017-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01017-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:23:49Z","timestamp":1628612629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-019-01017-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01017-1","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12325-020-01249-6","asserted-by":"object"}]},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"15 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original article Ninth and Tenth authors were incorrectly omitted from the author group. The correct author group is Joris Vandenbossche, Wolfgang Jessner, Maarten van den Boer, Jeike Biewenga, Jan Martin Berke, Willem Talloen, Loeckie De Zwart, Jan Snoeys, Koen Vandyck, John Fry, Jeysen Yogaratnam.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original article Ninth and Tenth authors were incorrectly omitted from the author group. The correct author group is Joris Vandenbossche, Wolfgang Jessner, Maarten van den Boer, Jeike Biewenga, Jan Martin Berke, Willem Talloen, Loeckie De Zwart, Jan Snoeys, Koen Vandyck, John Fry, Jeysen Yogaratnam.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}